Representatives of Fulgent Genetics to Participate in Oppenheimer’s 32nd Annual Healthcare Conference

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) , a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today announced that members of its management team are scheduled to virtually participate in Oppenheimer’s 32nd Annual...

Click to view original post